News and Comments

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Cytokinetics (CYTK) Xoma (XOMA) ImmunoGen (IMGN) Dynavax (DVAX) KERYX (KERX) Trastuzumab-DM1 Bristol-Myers Squibb (BMY) Aimmune Therapeutics (AIMT) Ionis (IONS) BIOMARIN (BMRN) Seattle Genetics (SGEN) Vertex (VRTX) Amgen (AMGN) Array Pharmaceuticals (ARRY) Sarepta (SRPT) ARCA (ABIO) Pluristem (PSTI) Sanofi (SNY) VANDA (VNDA) NANTKWEST (NK) SERES THERAPEUTICS (MCRB) TOKAI (TKAOI) ISIS (ISIS) Rapamune Multiple Myeloma SYNTA (SNTA) RenenxBio (RGNX) Prolor Biotech (PBTH) Jazz Pharmaceuticals (JAZZ) INNOVIVA (INVA) Valeant Pharmaceuticals International (VRX) Micromet (MITI) Alnylam (ALNY) Regeneron (REGN) CompuGen (CGEN) SUNESIS PHARMACEUTICALS (SNSS) Elan (ELN) KITE (KITE) Roche (RHHBY) Zerenex CRISPR Therapeutics (CRSP) GUARDIAN HEALTH Ariad (ARIA) Human Genome Sciences (HGSI) Ocular Therapeutix (OCUL) Revlimid (lenolidamide) NEKTAR (NKTR)) Herceptin Idenix (IDIX) Vitae Pharmaceuticals (VTAE) Merck (MRK) Bellicum (BLCM) Human Longevity (HLI) MODERNA Illumina (ILMN) AGOS (ARGS) Agenus (AGEN Prosensa (RNA) Auspex (ASPX) AstraZeneca (AZN) Anacor (ANAC) Sangamo (SGMO) Velcade (bortezomib) ZALTRAP™ ACADIA (ACAD) galapagos (GLPG) REGULUS (RGLS) Editas (EDIT) Tysabri Biocryst (BCRX) Intrexon (XON) NOVOCURE (NVCR) Telaprevir CEMPRA (CEMP) ABBVIE (ABBV) HALOZYME (HALO) PTC Therapeutics (PTCT) Incyte (INCY) Exelixis (EXEL) Spike Therapeutics (ONCE) Genentech Adaptimmune (ADAP) Benlysta (belimumab) GlaxoSmithKline (GSK) Endometrial Cancer AERIE PHARMACEUTICALS Theravance (THRX) Agenus (AGEN) Dendreon (DNDN) Ridaforolimus OSI (OSIP) Mirati Therapeutics (MRTX) ARGOS (ARGS) Advaxis (ADXS) Biogen Idec (BIIB) Sanofi-Aventis (SAN) JUNO (JUNO) Theravance Bio Pharma (TBPH) Alder Biopharmaceuticals (ALDR) Inovio (INO) Intercept (ICPT) C4 Therapeutics Anadys (ANDS) JOUNCE THERAPEUTICS (JNCE) Global Cell Therapeutics (GBT) Galena (GALE) Intermune (ITMN) Roche (ROCHE) Sequenom (SQNM) ADVENTRIX (ANX) PORTOLA (PTLA) IDERA (IDRA) Ziofpharm (ZIOP) Onyx (ONXX) Abbott Laboratories (ABT) Gilead (GILD) Sanofi (SNA)